Private equity firm Everstone Group, via its platform Everlife, has acquired Malaysia-based Chemopharm Sdn Bhd., which provides products and services’ solutions to laboratory, research and medical facilities in Southeast Asia, the firm said in a statement.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
